With treatment options such as oral medication kits or compounded GLP-1 injections, plans are personalized to your body, health history, and weight loss goals. Hers' science-backed program ...

Caroline Igo (she/her/hers ... to reach a healthy weight and improve your overall health, there are certain things you should keep in mind before choosing a weight loss program.

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Hims & Hers (HIMS) made a killing last year selling ... Still, the company expects its weight-loss business to generate at least $725 million in 2025. The company already offers monthly ...

The rapid rise of GLP-1 weight-loss drugs has come with a raucous side show—a wave of copycat drugs unbound by drug patents. The knockoff surge was led by Hims & Hers Health, the telehealth firm that ...

Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...

Hims & Hers shares fell on Tuesday, a day after the company released fourth-quarter results that disappointed on gross margin and outlined changes to its weight loss business. The company reported ...

Hims & Hers said it expects between $2.3 billion and $2.4 billion in revenue this year. The company added that it expects its weight loss offerings to generate at least $725 million in revenue ...